A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)

NCT04203186 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped Funding was lost due to the COVID19 Pandemic

Conditions

Plasmodium Falciparum

Interventions

DRUG: atovaquone-proguanil

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]